Suregene Receives NIH Grant to Develop Schizophrenia Test | GenomeWeb

NEW YORK (GenomeWeb News) – Suregene said last week that it has received a $497,000 grant from the National Institute of Mental Health to develop a test for the early detection of schizophrenia.

According to the company, the test focuses on two genetic variations observed in some patients with the mental disorder. The company hopes the test will allow physicians to gauge the risk of a patient developing schizophrenia, as well as help with the development of personalized therapies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.